Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer.
Maccarinelli F, Coltrini D, Mussi S, Bugatti M, Turati M, Chiodelli P, Giacomini A, De Cillis F, Cattane N, Cattaneo A, Ligresti A, Asperti M, Poli M, Vermi W, Presta M, Ronca R. Maccarinelli F, et al. Among authors: coltrini d. Cell Death Discov. 2023 Mar 6;9(1):81. doi: 10.1038/s41420-023-01383-4. Cell Death Discov. 2023. PMID: 36872341 Free PMC article.
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, Ligresti A, Presta M, Ronca R. Chiodelli P, et al. Among authors: coltrini d. Cancer Lett. 2022 Feb 1;526:217-224. doi: 10.1016/j.canlet.2021.11.030. Epub 2021 Dec 1. Cancer Lett. 2022. PMID: 34861311
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer.
Cerasuolo M, Maccarinelli F, Coltrini D, Mahmoud AM, Marolda V, Ghedini GC, Rezzola S, Giacomini A, Triggiani L, Kostrzewa M, Verde R, Paris D, Melck D, Presta M, Ligresti A, Ronca R. Cerasuolo M, et al. Among authors: coltrini d. Cancer Res. 2020 Apr 1;80(7):1564-1577. doi: 10.1158/0008-5472.CAN-18-3637. Epub 2020 Feb 6. Cancer Res. 2020. PMID: 32029552
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer.
Mahmoud AM, Kostrzewa M, Marolda V, Cerasuolo M, Maccarinelli F, Coltrini D, Rezzola S, Giacomini A, Mollica MP, Motta A, Paris D, Zorzano A, Di Marzo V, Ronca R, Ligresti A. Mahmoud AM, et al. Among authors: coltrini d. Pharmacol Res. 2023 Mar;189:106683. doi: 10.1016/j.phrs.2023.106683. Epub 2023 Feb 1. Pharmacol Res. 2023. PMID: 36736415 Free article.
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.
Ronca R, Giacomini A, Di Salle E, Coltrini D, Pagano K, Ragona L, Matarazzo S, Rezzola S, Maiolo D, Torrella R, Moroni E, Mazzieri R, Escobar G, Mor M, Colombo G, Presta M. Ronca R, et al. Among authors: coltrini d. Cancer Cell. 2015 Aug 10;28(2):225-39. doi: 10.1016/j.ccell.2015.07.002. Cancer Cell. 2015. PMID: 26267536 Free article.
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
Ronca R, Di Salle E, Giacomini A, Leali D, Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W, Presta M. Ronca R, et al. Among authors: coltrini d. Mol Cancer Ther. 2013 Dec;12(12):2760-71. doi: 10.1158/1535-7163.MCT-13-0487. Epub 2013 Oct 15. Mol Cancer Ther. 2013. PMID: 24130051
50 results